NEW YORK (GenomeWeb News) — The Burnham Institute will use Morphosys’ HuCAL GOLD-based antibodies for medical research, Morphosys said today.
 
HuCAL GOLD was developed by AbD Serotec, a MorphoSys subsidiary, and will be used to “identify and validate target molecules with potential medical implications” to help the Burnham Institute advance a number of ongoing programs.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.